Hypertensive nephropathy screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Hypertensive nephropathy}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References==..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hypertensive nephropathy}} | {{Hypertensive nephropathy}} | ||
{{CMG}}; {{AE}} {{AN}} | |||
==Screening== | |||
* [[Microproteinuria]] (less than 300 mg/ dl) is the first sign of renal damage secondary to hypertension. | |||
* It is widely used as a screening technique to detect renal damage at an early stage. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 15:07, 6 February 2013
|
Hypertensive nephropathy Microchapters |
|
Differentiating Hypertensive Nephropathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hypertensive nephropathy screening On the Web |
|
American Roentgen Ray Society Images of Hypertensive nephropathy screening |
|
Risk calculators and risk factors for Hypertensive nephropathy screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Screening
- Microproteinuria (less than 300 mg/ dl) is the first sign of renal damage secondary to hypertension.
- It is widely used as a screening technique to detect renal damage at an early stage.